Latest News
Latest News
News & Press
Business Achievements
- Arthrex Ranked No. 4 on TIME Magazine’s List of America’s Best Private Companies2 September 2026, 6:10 pm
Arthrex has been ranked No. 4 on TIME Magazine’s list of the 500 Best Private Companies in America.“This is a powerful recognition of our unique culture and continuous reinvestment in...
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)27 August 2026, 4:54 pm
August 25, 2026NOVATO, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and...
- OMEZA LLC Named No. 230th on the 2026 Inc. 5000 List13 August 2026, 4:46 pm
OMEZA LLCAug 13, 2026, 07:25 ETSARASOTA, Fla., Aug. 13, 2026 /PRNewswire-PRWeb/ -- [OMEZA] today announced it has been ranked No. 230th on the 2026 Inc. 5000 list, the annual list...
- Biodefense is force protection: Ready today, prepared for tomorrow12 August 2026, 3:14 pm
A decorated combat aviator and biotech CEO advocates preparing for novel viral threats before the next crisis.By Thomas K. Equels, CEO of AIM ImmunoTech on August 11, 2026 8:26 amAmerica...
- NanoNeurosciences Reaches a Landmark FDA Milestone, Accelerating the Path to the Clinic23 July 2026, 3:54 pm
NanoNeurosciences is proud to announce the completion of its Pre-Investigational New Drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA) for its lead candidate, NNS-01, a landmark achievement...
- Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential7 July 2026, 4:00 pm
C1 Monoclonal Antibody Progress for RSV and MalariaFollowing Full $3.1 Million Gates Foundation Grant FundingJUPITER, Fla. — July 7, 2026 — Dyadic International, Inc. (Nasdaq: DYAI) (“Dyadic” or the “Company”), d/b/a...
- FORGE Coalition Launches to Position Tampa Bay as Southeast Hub for Radiopharmaceutical Innovation,28 May 2026, 3:01 pm
FORGE Coalition Launches to Position Tampa Bay as Southeast Hub for Radiopharmaceutical Innovation, Training and ProductionMay 26, 2026TAMPA, Fla. (May 27, 2026) — A new regional coalition, the Florida Oncology...
- Omeza announces closing of $8.5 Million Series A financing21 April 2026, 3:25 pm
Omeza announces closing of $8.5 Million Series A financing co-led by Astanor and BluKap Ventures, with participation from Catalyst Investments Round positions Omeza to accelerate clinical development and scale...
- Defence Therapeutics Announces Closing Of Private Placement Of Units For Gross Proceeds Of$9,595,00031 March 2026, 9:51 pm
March 9, 2026Montreal, QC, Canada, March 9, 2026 — Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), a publicly traded biotechnology and precision intracellular drug-delivery company,...
- Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch17 February 2026, 8:32 pm
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human AlbuminJUPITER, Fla. and ANKENY, Iowa, Feb. 17, 2026 (GLOBE NEWSWIRE) — Dyadic Applied BioSolutions (“Dyadic”, “we”,...
